Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
6.63
+0.28 (4.41%)
Jul 7, 2026, 4:00 PM EDT - Market closed
Harvard Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.1 | 8.61 | 4.11 | 4.28 | 4.51 | 7.82 |
Cash & Short-Term Investments | 7.1 | 8.61 | 4.11 | 4.28 | 4.51 | 7.82 |
Cash Growth | 27.98% | 109.69% | -4.09% | -4.99% | -42.36% | -5.96% |
Accounts Receivable | 14.57 | 16.04 | 14.87 | 16.1 | 16.71 | 21.83 |
Inventory | 22.21 | 20.81 | 23.25 | 24.72 | 26.44 | 27.59 |
Other Current Assets | 3.6 | 2.76 | 2.9 | 3.94 | 3.47 | 4.34 |
Total Current Assets | 47.48 | 48.23 | 45.12 | 49.04 | 51.12 | 61.58 |
Net Property, Plant & Equipment | 11.6 | 11.96 | 11.24 | 8.75 | 9.18 | 10.31 |
Other Intangible Assets | 6.91 | 7.64 | 11.13 | 16.04 | 21.01 | 27.39 |
Goodwill | 9.37 | 9.56 | 56.32 | 57.07 | 56.26 | 57.69 |
Other Long-Term Assets | 2.58 | 2.69 | 2.83 | 6.47 | 7.78 | 5.38 |
Total Assets | 77.94 | 80.07 | 126.64 | 137.37 | 145.36 | 162.34 |
Accounts Payable | 5.29 | 3.65 | 4.79 | 5.55 | 6.45 | 4.91 |
Current Portion of Long-Term Debt | - | - | 36.96 | 5.86 | 3.81 | 3.24 |
Current Portion of Leases | - | - | - | - | 2.14 | 2.14 |
Unearned Revenue | 3.67 | 3.45 | 3.81 | 4.51 | 3.37 | 4.27 |
Other Current Liabilities | 14.91 | 14.86 | 9.41 | 10.62 | 7.49 | 10.76 |
Total Current Liabilities | 23.86 | 21.96 | 54.96 | 26.54 | 23.25 | 25.32 |
Long-Term Debt | 36.21 | 35.87 | - | 30.7 | 43.01 | 45.1 |
Long-Term Leases | 6.36 | 6.88 | 6.38 | 4.79 | 5.28 | 6.49 |
Other Long-Term Liabilities | 1.46 | 1.63 | 1.97 | 2.25 | 1.6 | 2.04 |
Total Long-Term Liabilities | 44.03 | 44.38 | 8.35 | 37.75 | 49.89 | 53.63 |
Total Liabilities | 67.89 | 66.34 | 63.3 | 64.29 | 73.14 | 78.94 |
Common Stock | 0.45 | 0.45 | 0.44 | 0.43 | 0.45 | 0.45 |
Additional Paid-in Capital | 240.05 | 239.67 | 236.58 | 232.44 | 229.01 | 225.65 |
Accumulated Other Comprehensive Income | -12.31 | -11.67 | -15.67 | -14.19 | -15.05 | -10.03 |
Retained Earnings | -218.13 | -214.71 | -158.01 | -145.61 | -142.19 | -132.67 |
Shareholders' Equity | 10.05 | 13.73 | 63.34 | 73.07 | 72.22 | 83.4 |
Total Liabilities & Equity | 77.94 | 80.07 | 126.64 | 137.37 | 145.36 | 162.34 |
Total Debt | 42.57 | 42.75 | 43.34 | 41.36 | 54.24 | 56.96 |
Net Cash (Debt) | -35.47 | -34.14 | -39.23 | -37.07 | -49.73 | -49.14 |
Net Cash Per Share | -7.96 | -7.69 | -9.01 | -8.74 | -12.01 | -12.18 |
Book Value | 10.05 | 13.73 | 63.34 | 73.07 | 72.22 | 83.4 |
Book Value Per Share | 2.26 | 3.09 | 14.55 | 17.23 | 17.44 | 20.67 |
Tangible Book Value | -6.23 | -3.46 | -4.12 | -0.03 | -5.05 | -1.67 |
Tangible Book Value Per Share | -1.40 | -0.78 | -0.95 | -0.01 | -1.22 | -0.41 |